ZANG Peng, LI Jinxia, LI Ji, ZHANG Huizhi, GU Yan. Experimental study of Huangqi Guizhi Wuwu Decoctionin prevention and treatment of rats model with deep venous thrombosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 12-17. DOI: 10.7619/jcmp.20220385
Citation: ZANG Peng, LI Jinxia, LI Ji, ZHANG Huizhi, GU Yan. Experimental study of Huangqi Guizhi Wuwu Decoctionin prevention and treatment of rats model with deep venous thrombosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 12-17. DOI: 10.7619/jcmp.20220385

Experimental study of Huangqi Guizhi Wuwu Decoctionin prevention and treatment of rats model with deep venous thrombosis

More Information
  • Received Date: February 08, 2022
  • Available Online: July 01, 2022
  • Objective 

    To investigate the mechanism of Huangqi Guizhi Wuwu Decoction in prevention and treatment of rats model with deep venous thrombosis (DVT).

    Methods 

    A total of 40 male SD rats with specific pathogen free (SPF) grade were randomly divided into sham operation group,model group,Chinese medicine group and heparin calcium group,with 10 rats in each group. Except for the sham operation group,the femoral vein thrombosis models of rats with incomplete ligation were established in the other three groups. In the Chinese medicine group,2.0 g/(kg·d) of freeze-dried powder solution of Huangqi Guizhi Wuwu Decoction was given by intragastric administration; in the heparin calcium group,351.43 IU/(kg·d) of low molecular weight heparin calcium was given by subcutaneous injection; in the sham operation group and the model group,distilled water was given by intragastric administration; the administration time for rats in each group was from 7 days before modeling to 7 days after modeling,once a day,lasting for 14 days. After treatment,the abdominal aorta blood of rats in each group was collected to detect the coagulation indicators such as activated partial thromboplastin time (APTT),prothrombin time (PT),thrombin time (TT),fibrinogen (FIB) and D-dimer (D-D),and the plasma metabolites were analyzed; the femoral vein segments of rats in each group were collected to observe the histomorphological differences of venous thrombosis segments.

    Results 

    Compared with the sham operation group,the levels of FIB and D-D in the model group increased significantly,and APTT,PT and TT shortened significantly (P < 0.05); compared with the model group,the FIB and D-D levels decreased significantly in the heparin calcium group and the Chinese medicine group,while APTT,PT and TT prolonged significantly (P < 0.05); compared with the heparin calcium group,the level of D-D in the Chinese medicine group was significantly lower (P < 0.05). Plasma metabolic analysis showed that there were 27 differential metabolites between the model group and the sham operation group; Huangqi Guizhi Wuwu Decoction could significantly restore 14 differential metabolites,involving the improvement of vitamin K,trimethylamine N-oxide (TMAO),anserine,L-carnosine,carnitine metabolism,bile acid metabolism and lipid metabolism; low molecular weight heparin could significantly restore 8 differential metabolites,involving TMAO,anserine,L-carnosine,carnitine metabolism and amino acid metabolism. Histomorphological results showed that there was no thrombosis in the venous lumen in the sham operation group; in the model group,the venous lumen was filled with thrombus,and the inflammatory cell infiltration was more serious; in the heparin calcium group,part of the thrombus in the venous lumen disintegrated,part of the thrombus contracted,and the inflammatory cell infiltration was lighter than that in the model group; in the Chinese medicine group,most of the thrombus in the venous lumen disintegrated and disappeared,a small amount of thrombus remained and contracted,and the inflammatory cell infiltration in the vascular wall was light,which indicated the degree of pathological damage was light.

    Conclusion 

    Huangqi Guizhi Wuwu Decoction has the effects of anticoagulation,improving metabolic disorder,inhibiting thrombosis,protecting vascular endothelial cells and reducing inflammatory cell infiltration,which may be the important mechanism for treatment of DVT.

  • [1]
    KOSKINAS P,INTAS G,STERGIANNIS P,et al. Incidence of deep vein thrombosis and its effect on health-related quality of life among nurses of Greek public hospitals:a multicenter study[J].Adv Exp Med Biol,2021,1337:37-45.
    [2]
    COHEN A T,AGNELLI G,ANDERSON F A,et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality[J].Thromb Haemost,2007,98(4).756-764.
    [3]
    ARSHAD N,BJORI E,HINDBERG K,et al. Recurrence and mortality after first venous thromboembolism in a large population-based cohort[J].J Thromb Haemost,2017,15(2).295-303. doi: 10.1111/jth.13587
    [4]
    HEIT J A,SPENCER F A,WHITE R H. The epidemiology of venous thromboembolism[J].J Thromb Thrombolysis,2016,41(1).3-14. doi: 10.1007/s11239-015-1311-6
    [5]
    孙聪,王钧,常永梅. 国内深静脉血栓流行病学特征和危险因素研究进展[J].齐齐哈尔医学院学报,2015,36(15).2282-2283. https://www.cnki.com.cn/Article/CJFDTOTAL-QQHB201515058.htm
    [6]
    马晓婷,柴秀英,沈辛酉,等. 上海、西宁地区下肢深静脉血栓病人临床流行病学特征分析[J].护理研究,2016,30(1).113-115. doi: 10.3969/j.issn.1009-6493.2016.01.038
    [7]
    戴璐璐. 深静脉血栓形成住院患者生活质量现状及影响因素分析[D].武汉:武汉轻工大学,2021.
    [8]
    于洋,王景,张海丽. 中医药治疗下肢深静脉血栓研究进展[J].辽宁中医药大学学报,2019,21(2).137-140. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201902039.htm
    [9]
    赵志丽,赵远红,陈茂艳,等. 赵远红运用黄芪桂枝五物汤辨治肺癌下肢静脉栓塞症验案1则[J].上海中医药杂志,2018,52(12).29-30. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201812009.htm
    [10]
    戴越保. 黄芪桂枝五物汤预防膝关节置换术后深静脉血栓的临床研究[D].合肥:安徽中医药大学,2014.
    [11]
    张朝顺,柯常江,冯起校,等. 建立更符合临床的深静脉血栓形成大鼠模型的研究[J].新医学,2014,45(10).647-651. doi: 10.3969/g.issn.0253-9802.2014.10.004
    [12]
    SMITH C A,WANT E J,O'MAILLE G,et al. XCMS:processing mass spectrometry data for metabolite profiling using nonlinear peak alignment,matching,and identification[J].Anal Chem,2006,78(3).779-787. doi: 10.1021/ac051437y
    [13]
    张福先,王深明. 静脉血栓栓塞症诊断与治疗[M].北京:人民卫生出版社,2013:73-73.
    [14]
    杨鹏,强晓军,苏海涛,等. 利伐沙班与低分子肝素预防脊柱骨折手术后下肢深静脉血栓的效果及不良反应比较[J].中国药物滥用防治杂志,2021,27(4).528-531. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYLF202104024.htm
    [15]
    胡天洋,蒋幼凡. 新型口服抗凝药治疗静脉血栓栓塞症的效果及安全性的Meta分析[J].河北医科大学学报,2019,40(3).286-291. doi: 10.3969/j.issn.1007-3205.2019.03.009
    [16]
    杨晓娜,赵良虎,黄金,等. 依诺肝素钠与磺达肝癸钠预防膝关节置换术后深静脉血栓的对比研究[J].中国医院用药评价与分析,2021,21(10).1176-1179. https://www.cnki.com.cn/Article/CJFDTOTAL-YYPF202110006.htm
    [17]
    RAJ K,CHANDNA S,DOUKAS S G,et al. Combined use of wells scores and D-dimer levels for the diagnosis of deep vein thrombosis and pulmonary embolism in COVID-19:a retrospective cohort study[J].Cureus,2021,13(9).e17687.
    [18]
    SKYE S M,ZHU W F,ROMANO K A,et al. Microbial transplantation with human gut commensals containing CutC is sufficient to transmit enhanced platelet reactivity and thrombosis potential[J].Circ Res,2018,123(10).1164-1176. doi: 10.1161/CIRCRESAHA.118.313142
  • Related Articles

    [1]ZHANG Qiong, LUO Qilin, WANG Kai. Application values of serum procalcitonin, anti-thrombin Ⅲ, D-dimer and four items of coagulation test in early diagnosis of pediatric sepsis[J]. Journal of Clinical Medicine in Practice, 2024, 28(21): 43-47. DOI: 10.7619/jcmp.20242011
    [2]LIU Jiaming, ZHENG Rui. Analysis in changs of coagulation function indexes in chronic obstructive pulmonary disease patients complicated with community-acquired pneumonia[J]. Journal of Clinical Medicine in Practice, 2020, 24(10): 68-71. DOI: 10.7619/jcmp.202010017
    [3]ZHAO Guiqin, GUO Zhenfeng. Correlation between fibrinogen, thrombus precursor protein and severity of coronary artery disease in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2018, (22): 1-4. DOI: 10.7619/jcmp.201822001
    [4]ZHENG Yinglan, FAN Liqing, JIANG Shunshun. Change and significance of d-dimer, partial thrombin time and fibrinogen in patients with ulcerative colitis[J]. Journal of Clinical Medicine in Practice, 2018, (15): 41-43. DOI: 10.7619/jcmp.201815010
    [5]WU Hongli, TIAN Ruixue, YE Qing, SONG Yujia. Expressions of brain natriuretic peptide, fibrinogen,hypersensitive C-reactive protein, D-Dimer and arterial blood gas analysis in acute exacerbation of chronic obstructive pulmonary disease patients complicated with pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2018, (3): 31-33,37. DOI: 10.7619/jcmp.201803008
    [6]ZHOU Qing, WEN Bing. Correlation between arterial blood gas analysis and serum D-dimer, fibrinogen and homocysteine in patients with COPD[J]. Journal of Clinical Medicine in Practice, 2015, (1): 26-28. DOI: 10.7619/jcmp.201501008
    [7]JIANG Hui, DU Jun, GU Jiming, GAO Qizhong, JIN Liugen, FEI Bojian. Effect comparison between laparoscopic surgery and laparotomy surgery on coagulation function in patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2014, (17): 155-157. DOI: 10.7619/jcmp.201417054
    [8]LIU Zhanghua. Effect of prostaglandin E1 on treatment of diabetic nephropathy and its influence on plasma fibrinogen[J]. Journal of Clinical Medicine in Practice, 2014, (13): 97-98,105. DOI: 10.7619/jcmp.201413032
    [9]LIU Yuming, XU Zhiqiang, ZHOU Borong, LIU Zifan, DENG Yanhua. Relationships between antithrombin Ⅲ,protein C, fibrinogen and progressive stroke[J]. Journal of Clinical Medicine in Practice, 2013, (11): 56-58. DOI: 10.7619/jcmp.201311018
    [10]HUANG Xue-yuan, LAN Ke-ning. Changes and correlation analysis of plasma D- dimer,fibrinogen and serum high sensitivity C- reactive protein in patients with progressive cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2012, (7): 99-101. DOI: 10.3969/j.issn.1672-2353.2012.07.034
  • Cited by

    Periodical cited type(17)

    1. 赵江华,陈云,蒋珺. 体位变换在早产新生儿呼吸窘迫综合征机械通气患儿中的应用效果. 妇儿健康导刊. 2025(04): 143-146+155 .
    2. 代苗英,蓝菊红. CH50 CD3~+及CD4~+在新生儿急性呼吸窘迫综合征患儿中的表达及意义. 中国妇幼保健. 2024(01): 44-48 .
    3. 周丽平,苏红. 基于集束化理念的气道分级管理在新生儿呼吸窘迫综合征机械通气患儿中的应用. 中外医学研究. 2024(16): 85-89 .
    4. 牛曼玉. 预警机制联合转变体位护理在新生儿肺炎中的应用效果. 中国民康医学. 2024(14): 186-189 .
    5. 胡龙,贺蛟龙,时淑娟,黄聪灵. 右美托咪定与咪达唑仑在ICU急性呼吸窘迫综合征行俯卧位通气患者中的镇静效果比较. 临床合理用药. 2024(23): 17-20 .
    6. 徐海萍,潘利飞. 俯卧位通气对急性呼吸窘迫综合征患者氧合状态和谵妄发生率的影响. 中国医药导报. 2024(16): 59-61 .
    7. 董惠仪,李莉,成玉萍. 早产儿俯卧位机械通气在新生儿呼吸窘迫综合征中的临床疗效分析. 婚育与健康. 2024(18): 40-42 .
    8. 叶淮金. 新生儿急性呼吸窘迫综合征发病机制及俯卧位通气治疗的研究进展. 中国社区医师. 2024(26): 4-6 .
    9. 林娇蓉,李科霞,许翠雯. 强化风险护理联合俯卧位通气对新生儿呼吸窘迫综合征的影响. 中国医药指南. 2024(32): 64-66 .
    10. 王万旭,何学坤. 保护性机械通气治疗新生儿脓毒血症合并急性呼吸窘迫综合征效果研究. 中华养生保健. 2024(21): 56-59 .
    11. 再乃甫·乃比江,艾图尼克·沙马瓦提,阿布来提·阿不都哈尔. 儿童脓毒症相关急性呼吸窘迫综合征的早期识别与治疗进展. 中国医学创新. 2024(36): 171-175 .
    12. 钟艳玲,刘彦彦. 肺透明膜病新生儿经鼻持续正压通气治疗中压力不稳定发生情况及危险因素分析. 中国当代医药. 2023(08): 123-126 .
    13. 汤媛. 先天性胸腔积液合并呼吸窘迫综合征1例的护理. 中国乡村医药. 2023(06): 81-82 .
    14. 丘文英,林艺坤,甘跃华. 俯卧位机械通气在新生儿呼吸窘迫综合征中的临床疗效分析. 中外医疗. 2023(18): 57-60 .
    15. 左园弋. 俯卧位通气在急性呼吸窘迫综合征患者中的应用价值. 婚育与健康. 2023(18): 58-60 .
    16. 杜遥,张妙联,邓鸿儒. 俯卧位通气联合布地奈德应用于新生儿呼吸窘迫综合征的临床观察. 中国医学创新. 2023(34): 140-143 .
    17. 李眉,陶建兰,王伏东,翟秀玲. 新生儿肺透明膜病经鼻持续正压通气治疗中通气压力不稳定风险的列线图模型构建. 实用临床医药杂志. 2023(24): 63-67 . 本站查看

    Other cited types(2)

Catalog

    Article views (135) PDF downloads (9) Cited by(19)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return